Kiley Juergens Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Kiley Juergens Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11	Closed	–	–	498
2018 Q3	$0	Hold	11	–	–	﹤0.01%	735
2018 Q2	$0	Buy	+11	New	+$3.44K	﹤0.01%	673
2018 Q1	–	Sell	-11	Closed	-$4K	–	481
2017 Q4	$4K	Buy	+11	New	+$4.46K	﹤0.01%	591

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Kiley Juergens Wealth Management's REGN Position: Q4 2018 in Review

Kiley Juergens Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2018, closing a stake of 11 shares.

Kiley Juergens Wealth Management first reported a position in REGN in Q4 2017 and held it in 3 quarters. The position peaked at $4K in Q4 2017. 670 funds tracked by Wall St. Rank hold REGN as of Q4 2018.

Kiley Juergens Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Kiley Juergens Wealth Management sold 11 Regeneron Pharmaceuticals shares in Q4 2018.
Kiley Juergens Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 3 quarters.
Kiley Juergens Wealth Management's Regeneron Pharmaceuticals position peaked at $4K in Q4 2017.
670 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2018.

Based on Kiley Juergens Wealth Management's 13F filing for Q4 2018, filed 15 Jan 2019.